🇺🇸 FDA
Patent

US 11602515

Pharmaceutical compositions comprising dimethyl fumarate

granted A61KA61K31/225A61K9/0053

Quick answer

US patent 11602515 (Pharmaceutical compositions comprising dimethyl fumarate) held by Almirall, S.A. expires Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Almirall, S.A.
Grant date
Tue Mar 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/225, A61K9/0053, A61K9/2009, A61K9/2018